Glatiramer acetate

From WikiMD.com Medical Encyclopedia

(Redirected from Copaxone)

Medication used to treat multiple sclerosis


Glatiramer acetate
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Glatiramer acetate is a medication used in the treatment of multiple sclerosis (MS), specifically for reducing the frequency of relapses in patients with relapsing-remitting multiple sclerosis (RRMS). It is marketed under the brand name Copaxone.

Mechanism of Action[edit | edit source]

Glatiramer acetate is a mixture of synthetic polypeptides composed of four amino acids: L-glutamic acid, L-lysine, L-alanine, and L-tyrosine. The exact mechanism by which glatiramer acetate exerts its effects in MS is not fully understood. However, it is believed to act by modifying immune processes that are thought to be responsible for the pathogenesis of MS. It is thought to induce a shift from a pro-inflammatory T-helper 1 (Th1) response to an anti-inflammatory T-helper 2 (Th2) response, thereby reducing inflammation and demyelination in the central nervous system.

Administration[edit | edit source]

Glatiramer acetate is administered by subcutaneous injection. The standard dosage is 20 mg per day or 40 mg three times a week, depending on the specific formulation prescribed. Patients are instructed to rotate injection sites to minimize the risk of injection site reactions.

Injection site reaction from Copaxone

Side Effects[edit | edit source]

Common side effects of glatiramer acetate include injection site reactions, such as redness, pain, swelling, and itching. Systemic reactions may also occur, including flushing, chest pain, palpitations, anxiety, and shortness of breath. These systemic reactions are usually transient and resolve without treatment.

Clinical Use[edit | edit source]

Glatiramer acetate is primarily used in the management of relapsing forms of multiple sclerosis. It has been shown to reduce the frequency of clinical exacerbations and slow the progression of disability in patients with RRMS. It is not a cure for MS but helps manage symptoms and reduce the frequency of relapses.

History[edit | edit source]

Glatiramer acetate was developed in the 1960s by researchers at the Weizmann Institute of Science in Israel. It was initially intended as a model compound to induce experimental autoimmune encephalomyelitis (EAE), an animal model of MS. However, it was found to have a protective effect against EAE, leading to its development as a treatment for MS. It was approved for medical use in the United States in 1996.

Related Pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD